Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

Blood (2012) 120 (21): 702.

https://doi.org/10.1182/blood.V120.21.702.702

Published: 2012

Journal Articles

Study of Causes of Death in Patients with Myelodysplastic Syndrome: A Single Institution Experience

Julia Montoro, MD, Teresa Vallespi, MD, PhD, Esther Sancho, MD, Olga Salamero, MD, Laura Lopez-Andreoni, MD, Carmen sanchez-Morata, MD, Mayda Navarrete, MD, Margarita Ortega, PhD, Sabela Bobillo, MD, Noelia Valdez, MD, Francesc Bosch, MD, PhD, David Valcárcel, MD

Blood (2011) 118 (21): 5026.

https://doi.org/10.1182/blood.V118.21.5026.5026

Published: 2011

Journal Articles

Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD)

David Valcárcel, MD, Vera Adema, Mar Mallo, Margarita Ortega, PhD, Benet Nomdedeu, MD, Guillermo Sanz, MD, Elisa Luño, MD, Del CaÃ‘izo Consuelo, MD, PhD, Javier De la Serna, MD, PhD, Maita Ardanaz, MD, Victor Marco, MD, Rosa Collado, Blanca Xicoy, MD, Francesc Sole, PhD, Teresa Vallespi, MD, PhD

Blood (2011) 118 (21): 1724.

https://doi.org/10.1182/blood.V118.21.1724.1724

Published: 2011

Journal Articles

Sustained Complete Metabolic Remission After Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE).

Joerg Halter, WM Michael Schuepbach, Carlo Casali, Ronit Elhasid, Keith Fay, Simon Hammans, Isabel Illa, Liliane Kappeler, Stephan Kraehenbuehl, Thomas Lehmann, Hanna Mandel, Ramon Marti, Heinrich Mattle, Kim H. Orchard, David Savage, Carolyn Sue, David Valcárcel, Alois Gratwohl, Michio Hirano

Blood (2009) 114 (22): 1181.

https://doi.org/10.1182/blood.V114.22.1181.1181

Published: 2009

Journal Articles

Validation of Comorbidity Indexes in Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation. the Hematopoietic Cell Transplantation Comorbidity Index Is the Best Predictor of NRM and Survival.

Pere Barba, Jose Luis Piñana, Alex Amoros, David Valcárcel, Rodrigo Martino, Anna Sureda, Javier Briones, Julio Delgado, Miquel Granell, Salut Brunet, Ma. Rosa Suñol, J. Sierra, MD

Blood (2008) 112 (11): 3277.

https://doi.org/10.1182/blood.V112.11.3277.3277

Published: 2008

Journal Articles

Comparison of Cyclosporine A and Mycophenolate Mofetil vs Cyclosporine A and Methotrexate in Reduced Intensity Conditioning HLA Sibling Allogeneic Stem Cell Transplantation. A Case-Match Single-Center Experience.

Jose L. Piñana, David Valcárcel, Rodrigo Martino, Rocio Parody, Anna Sureda, Javier Briones, Julio Delgado, Blanca Snchez, Salut Brunet, Jorge Sierra

Blood (2007) 110 (11): 4994.

https://doi.org/10.1182/blood.V110.11.4994.4994

Published: 2007

NARROW

Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

Study of Causes of Death in Patients with Myelodysplastic Syndrome: A Single Institution Experience

Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD)

Sustained Complete Metabolic Remission After Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE).

Validation of Comorbidity Indexes in Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation. the Hematopoietic Cell Transplantation Comorbidity Index Is the Best Predictor of NRM and Survival.

Comparison of Cyclosporine A and Mycophenolate Mofetil vs Cyclosporine A and Methotrexate in Reduced Intensity Conditioning HLA Sibling Allogeneic Stem Cell Transplantation. A Case-Match Single-Center Experience.

Email alerts

ASH Publications

American Society of Hematology

Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

Study of Causes of Death in Patients with Myelodysplastic Syndrome: A Single Institution Experience

Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD)

Sustained Complete Metabolic Remission After Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE).

Validation of Comorbidity Indexes in Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation. the Hematopoietic Cell Transplantation Comorbidity Index Is the Best Predictor of NRM and Survival.

Comparison of Cyclosporine A and Mycophenolate Mofetil vs Cyclosporine A and Methotrexate in Reduced Intensity Conditioning HLA Sibling Allogeneic Stem Cell Transplantation. A Case-Match Single-Center Experience.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only